Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group
ConclusionsProlonged survival can be expected in patients with EMC, in spite of a high rate of recurrence. Size is significantly associated with distant relapse. The type of NR4A3 translocation could influence outcome.
Source: Annals of Surgical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Chondrosarcoma | Genetics | Italy Health | Sarcomas | Study | Translocation